Mechanisms of opioid-induced tolerance and hyperalgesia
- PMID: 17723928
- DOI: 10.1016/j.pmn.2007.02.004
Mechanisms of opioid-induced tolerance and hyperalgesia
Abstract
Opioid tolerance and opioid-induced hyperalgesia are conditions that negatively affect pain management. Tolerance is defined as a state of adaptation in which exposure to a drug induces changes that result in a decrease of the drug's effects over time. Opioid-induced hyperalgesia occurs when prolonged administration of opioids results in a paradoxic increase in atypical pain that appears to be unrelated to the original nociceptive stimulus. Complex intracellular neural mechanisms, including opioid receptor desensitization and down-regulation, are believed to be major mechanisms underlying opioid tolerance. Pain facilitatory mechanisms in the central nervous system are known to contribute to opioid-induced hyperalgesia. Recent research indicates that there may be overlap in the two conditions. This article reviews known and hypothesized pathophysiologic mechanisms surrounding these phenomena and the clinical implications for pain management nurses.
Similar articles
-
Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats.Neuropsychopharmacology. 2007 Oct;32(10):2217-28. doi: 10.1038/sj.npp.1301340. Epub 2007 Feb 14. Neuropsychopharmacology. 2007. PMID: 17299508
-
[How to avoid opioid tolerance].MMW Fortschr Med. 2011 Sep 8;153(36):46-8. doi: 10.1007/BF03368726. MMW Fortschr Med. 2011. PMID: 21932644 German. No abstract available.
-
Opioid induced hyperalgesia: clinical implications for the pain practitioner.Pain Physician. 2009 May-Jun;12(3):679-84. Pain Physician. 2009. PMID: 19461836 Review.
-
Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery.Neurosci Lett. 2006 Mar 20;396(1):44-9. doi: 10.1016/j.neulet.2005.11.009. Epub 2005 Dec 15. Neurosci Lett. 2006. PMID: 16343768
-
Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients?Pain Manag Nurs. 2013 Sep;14(3):e67-83. doi: 10.1016/j.pmn.2011.04.002. Epub 2011 Jun 25. Pain Manag Nurs. 2013. PMID: 23972873 Review.
Cited by
-
β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons.Mol Pain. 2014 Aug 1;10:50. doi: 10.1186/1744-8069-10-50. Mol Pain. 2014. PMID: 25085415 Free PMC article.
-
Adherence to Analgesics Among Outpatients Seriously Ill With Cancer.Cancer Nurs. 2022 Sep-Oct 01;45(5):337-344. doi: 10.1097/NCC.0000000000001064. Epub 2022 Feb 16. Cancer Nurs. 2022. PMID: 35175950 Free PMC article.
-
Astaxanthin has a beneficial influence on pain-related symptoms and opioid-induced hyperalgesia in mice with diabetic neuropathy-evidence from behavioral studies.Pharmacol Rep. 2024 Dec;76(6):1346-1362. doi: 10.1007/s43440-024-00671-9. Epub 2024 Nov 12. Pharmacol Rep. 2024. PMID: 39528765 Free PMC article.
-
Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord.Front Neural Circuits. 2014 Jun 11;8:62. doi: 10.3389/fncir.2014.00062. eCollection 2014. Front Neural Circuits. 2014. PMID: 24966815 Free PMC article.
-
Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone.Drug Alcohol Depend. 2021 Sep 1;226:108869. doi: 10.1016/j.drugalcdep.2021.108869. Epub 2021 Jun 25. Drug Alcohol Depend. 2021. PMID: 34216862 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources